ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 16166 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 16166; 2) Community: the network communities that were significantly associated with the response to NSC 16166; 3) Molecule: the relationships between components within communities and NSC 16166; 4) MDR: the compounds that were significantly associated with the NSC 16166.

NSC Compound Enrichment Correlation
NSC 753394 3-[2-(5-fluoro-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0133012546828914 0.29136161
NSC 376265 Piperazine-1-carbothioic acid, 4-cycloheptyl-, [1-(2-pyridyl)ethylidene]hydrazide 0.0163859626459253 0.51384722
NSC 678404 Null 0.0163859626459253 0.28311857
NSC 703102 Null 0.0163859626459253 0.39492969
NSC 711618 Null 0.0163859626459253 0.21773196
NSC 727223 1-(3-dimethylarsino-3-thio-2-methyl-1-oxopropyl)-L-proline 0.0163859626459253 0.068973235
NSC 743691 Null 0.0163859626459253 0.12819004
NSC 746131 PYR-41 0.0163859626459253 0.10299629
NSC 175630 Toyocamycin, 6-amino- 0.0174563696971636 0.19558174
NSC 286122 Null 0.0174563696971636 0.15353394
Total:33  Current:8    [First] [Prev] [Next] [Last]